JARED HAINS: Open Payments
NPI 1780750091 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 14 payments from 8 companies in 2025. Trend: 2023 $178 · 2024 $16 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $104 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Philips North America LLC | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Amgen Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: VYNDAQEL, ELIQUIS, LEQVIO, MCOT, AMVUTTRA, FUROSCIX, REPATHA, JARDIANCE.
Industry payments across UT — which companies pay providers there.
